← The Wire
KLRSNasdaq
Kalaris Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1754068
Developing novel treatments for prevalent retinal diseases with unmet medical needs
red 8-K · 90d
$103M
Market cap
$4.21
Last close
-2.4%
1D
-4.2%
5D
122K
Volume
Price · last 39 sessions-23.8%
May 4L $4.08 · H $5.53Jun 29
132
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 2026SC 13D/ASC 13D/AMay 22, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KExecutive ChangeApr 10, 202610-K10-KMar 17, 20268-KResults of OperationsMar 17, 20268-KReg FD DisclosureMar 9, 2026SC 13D/ASC 13D/AFeb 17, 2026SC 13D/ASC 13D/ADec 22, 20258-KMaterial Agreement · Equity IssuanceDec 18, 20258-KReg FD Disclosure · Company UpdateDec 17, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KExecutive ChangeNov 3, 202510-Q10-QAug 13, 20258-KShareholder VoteAug 13, 20258-KResults of OperationsAug 13, 2025DEFA14ADEFA14AJul 1, 2025DEF 14ADEF 14AJul 1, 20258-KCompany UpdateJun 20, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 20258-KExecutive ChangeApr 16, 20258-KExecutive ChangeApr 4, 20258-KChange of Control · Executive ChangeMar 18, 20258-KExecutive Change · Shareholder VoteMar 12, 202510-K10-KMar 7, 2025425425Jan 15, 20258-KSecurity-Holder Rights · Bylaw AmendmentJan 15, 2025425425Jan 10, 20258-KCompany UpdateJan 10, 2025425425Jan 10, 20258-KShareholder VoteJan 10, 2025425425Dec 20, 20248-KExecutive ChangeDec 20, 2024S-4S-4Dec 9, 2024425425Dec 9, 2024DEF 14ADEF 14ADec 6, 202410-Q10-QNov 12, 2024425425Nov 8, 2024425425Nov 8, 2024425425Nov 8, 2024425425Nov 8, 2024425425Nov 8, 2024425425Nov 8, 20248-KMaterial Agreement · Reg FD DisclosureNov 8, 2024SC 13GSC 13GOct 11, 202410-Q10-QAug 9, 20248-KAgreement TerminatedJul 2, 20248-KAgreement TerminatedJun 11, 20248-KShareholder VoteJun 7, 20248-KExecutive ChangeJun 3, 202410-Q10-QMay 13, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KMar 15, 20248-KDelisting NoticeFeb 12, 2024SC 13GSC 13GFeb 1, 2024SC 13GSC 13GJan 9, 20248-KExit / Disposal CostsJan 4, 20248-KReg FD Disclosure · Company UpdateDec 22, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KMaterial Agreement · Company UpdateJun 26, 2023424B5424B5Jun 22, 2023424B5424B5Jun 21, 20238-KCompany UpdateJun 21, 20238-KBylaw Amendment · Shareholder VoteMay 16, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AMar 31, 2023DEF 14ADEF 14AMar 31, 20238-KExecutive Change · Reg FD DisclosureFeb 23, 202310-K10-KFeb 15, 20238-KResults of Operations · Reg FD DisclosureFeb 15, 2023
Insider Activity
In the 90 days to Mar 20, 2026: 1 sold $13K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Hagen Brett RChief Accounting Officer | Sell | 1,915 | $6.72 | $13K |
| Dec 18, 2025 | Samsara Opportunity Fund, L.P.TenPercentOwner | Buy | 479,847 | $10.42 | $5.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance